诚信认证:
工商注册信息已核实!
快速导航
产品分类
微信二维码
Minisite
不对称合成
Abemaciclib
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
阿拉丁 | 生产商 | 上海 | 现货 |
产品参数
货号 | CAS号 | 价格(元) | 操作 |
---|---|---|---|
L190223-100mg | 1231929-97-7 | 239 | 询价 |
L190223-1g | 1231929-97-7 | 1299 | 询价 |
L190223-5g | 1231929-97-7 | 4999 | 询价 |
产品介绍
属性
存贮条件 | 储存温度2-8℃ |
描述
产品介绍 | Abemaciclib highly selective inhibits the complexes CDK4/ cyclin D1 (IC50 =2 nmol/L) and CDK6/cyclin D1 (IC50 =10 nmol/L), with no activity against other CDK/cyclin complexes or cell-cycle-related kinases within the nanomolar ranges, except for inhibition of CDK9 at IC50 at least five times higher. Besides the cell-cycle dependent activity, abemaciclib is able to boost antitumor immunity by potentiating tumor antigen presentation and selectively suppressing proliferation of regulatory T (Treg) cells at the same time. Consistent with its activity against CDK4 and CDK6, abemaciclib inhibits RB phosphorylation and leads to G1 arrest in RB-proficient cell lines. In vitro, treatment with abemaciclib resulted in increased activation of human T cells and upregulated expression of antigen presentation genes in MCF-7 breast cancer cells. |
别名 | N-[5-[(4-乙基-1-哌嗪基)甲基]-2-吡啶基]-5-氟-4-[4-氟-2-甲基-1-异丙基-1H-苯并咪唑-6-基]-2-嘧啶胺;玻玛西林; ; |
Abemaciclib信息由上海阿拉丁生化科技股份有限公司为您提供,如您想了解更多关于Abemaciclib报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途